Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity

被引:106
作者
Anjani, Kavya [1 ,2 ,3 ]
Lhomme, Marie [3 ]
Sokolovska, Nataliya [1 ,2 ,3 ]
Poitou, Christine [1 ,2 ,3 ]
Aron-Wisnewsky, Judith [1 ,2 ,3 ]
Bouillot, Jean-Luc [5 ]
Lesnik, Philippe [3 ,4 ,6 ]
Bedossa, Pierre [7 ,8 ]
Kontush, Anatol [3 ,4 ,6 ]
Clement, Karine [1 ,2 ,3 ]
Dugail, Isabelle [1 ,2 ,3 ]
Tordjman, Joan [1 ,2 ,3 ]
机构
[1] Univ Paris 06, Sorbonne Univ, Nutri Team, ICAN,UMR S 1166, F-75005 Paris, France
[2] INSERM, UMR S U1166, Nutri Team, F-75013 Paris, France
[3] Hop La Pitie Salpetriere, AP HP, ICAN, F-75013 Paris, France
[4] INSERM, UMR S U1166, Dyslipidemia Inflammat & Atherosclerosis Team, F-75013 Paris, France
[5] Ambroise Pare Hosp, Assistance Publ Hop Paris, Dept Surg, Boulogne, France
[6] Univ Paris 06, Sorbonne Univ, Dyslipidemia Inflammat & Atherosclerosis Team, ICAN,UMR S 1166 1, F-75005 Paris, France
[7] Beaujon Hosp, Assistance Publ Hop Paris, Dept Pathol, Clichy, France
[8] Univ Paris Diderot, Ctr Rech Bichat Beaujon, INSERM, U773, Paris, France
关键词
Lipidomics; Visceral adipose tissue; Glycerophosphatidylglycerols; Glycerophosphatidylethanolamines; Bariatric surgery; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS NASH; TYPE-2; DIABETES-MELLITUS; OMENTAL ADIPOSE-TISSUE; INSULIN-RESISTANCE; ALANINE AMINOTRANSFERASE; CARDIOVASCULAR-DISEASE; MORBID-OBESITY; ASSOCIATION; PREVALENCE;
D O I
10.1016/j.jhep.2014.11.002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background & Aims: Non-alcoholic steatohepatitis (NASH) is characterized by steatosis, lobular inflammation, hepatocyte ballooning with fibrosis in severe cases, and high prevalence in obesity. We aimed at defining NASH signature in morbid obesity by mass spectrometry-based lipidomic analysis. Methods: We analyzed systemic blood before and 12 months after bariatric surgery, along with portal blood and adipose tissue lipid efflux collected from obese women at the time of surgery (9 structural classes, 150 species). Results: Increased concentrations of several glycerophosphocholines (PC), glycerophosphoethanolamines (PE), glycerophosphoinositols (PI), glycerophosphoglycerols (PG), lyso-glycerophosphocholines (LPC), and ceramides (Cer) were detected in systemic circulation of NASH subjects. Post-surgery weight loss (12 months) improved the levels of liver enzymes, as well as several lipids, but most PG and Cer species remained elevated. Analysis of lipids from hepatic portal system at the time of surgery revealed limited lipid alterations compared to systemic circulation, but PG and PE classes were found significantly increased in NASH subjects. We evaluated the contribution of visceral adipose tissue to lipid alterations in portal circulation by measuring adipose tissue lipid efflux ex vivo, and observed only minor alterations in NASH subjects. Interestingly, integration of clinical and lipidomic data (portal and systemic) led us to define a NASH signature in which lipids and clinical parameters are equal contributors. Conclusions: Circulatory (portal and systemic) phospholipid profiling and clinical data defines NASH signature in morbid obesity. We report weak contribution of visceral adipose tissue to NASH-related portal lipid alterations, suggesting possible contribution from other organs draining into hepatic portal system. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:905 / 912
页数:8
相关论文
共 41 条
[1]
A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients [J].
Anty, R. ;
Iannelli, A. ;
Patouraux, S. ;
Bonnafous, S. ;
Lavallard, V. J. ;
Senni-Buratti, M. ;
Ben Amor, I. ;
Staccini-Myx, A. ;
Saint-Paul, M. -C. ;
Berthier, F. ;
Huet, P. -M. ;
Le Marchand-Brustel, Y. ;
Gugenheim, J. ;
Gual, P. ;
Tran, A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (11-12) :1315-1322
[2]
The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women [J].
Arun, Janani ;
Clements, Ronald H. ;
Lazenby, Audrey J. ;
Leeth, Ruth R. ;
Abrams, Gary A. .
OBESITY SURGERY, 2006, 16 (10) :1351-1358
[3]
Ethnicity and nonalcoholic fatty liver disease [J].
Bambha, Kiran ;
Belt, Patricia ;
Abraham, Maria ;
Wilson, Laura A. ;
Pabst, Mark ;
Ferrell, Linda ;
Unalp-Arida, Aynur ;
Bass, Nathan .
HEPATOLOGY, 2012, 55 (03) :769-780
[4]
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients [J].
Bedossa, Pierre ;
Poitou, Christine ;
Veyrie, Nicolas ;
Bouillot, Jean-Luc ;
Basdevant, Arnaud ;
Paradis, Valerie ;
Tordjman, Joan ;
Clement, Karine .
HEPATOLOGY, 2012, 56 (05) :1751-1759
[5]
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953
[6]
Free fatty acids and pathogenesis of type 2 diabetes mellitus [J].
Bergman, RN ;
Ader, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (09) :351-356
[7]
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? [J].
Bhatia, Lokpal S. ;
Curzen, Nicholas P. ;
Calder, Philip C. ;
Byrne, Christopher D. .
EUROPEAN HEART JOURNAL, 2012, 33 (10) :1190-+
[8]
PORTAL ADIPOSE-TISSUE AS A GENERATOR OF RISK-FACTORS FOR CARDIOVASCULAR-DISEASE AND DIABETES [J].
BJORNTORP, P .
ARTERIOSCLEROSIS, 1990, 10 (04) :493-496
[9]
Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass [J].
Boza, C ;
Riquelme, A ;
Ibañez, L ;
Duarte, I ;
Norero, E ;
Viviani, P ;
Soza, A ;
Fernandez, JI ;
Raddatz, A ;
Guzman, S ;
Arrese, M .
OBESITY SURGERY, 2005, 15 (08) :1148-1153
[10]
Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids Relevance to Cellular Cholesterol Efflux, Antioxidative, Antithrombotic, Anti-Inflammatory, and Antiapoptotic Functionalities [J].
Camont, Laurent ;
Lhomme, Marie ;
Rached, Fabiana ;
Le Goff, Wilfried ;
Negre-Salvayre, Anne ;
Salvayre, Robert ;
Calzada, Catherine ;
Lagarde, Michel ;
Chapman, M. John ;
Kontush, Anatol .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (12) :2715-2723